Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study

Volume: 208, Pages: 35 - 38
Published: Dec 1, 2021
Abstract
•Hypercoagulability is a hallmark of COVID-19 patients.•It is unknown if pre-admission anticoagulant improves patient outcomes.•We studied 380 anticoagulant users and 380 matched controls with COVID-19.•Pre-admission anticoagulation was not associated with mortality and ICU...
Paper Details
Title
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
Published Date
Dec 1, 2021
Volume
208
Pages
35 - 38
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.